AI is remaking healthcare fast
Regulators and markets are tilting toward system‑level AI: the FDA increasingly favors ‘breakthrough’ labels for multi‑problem platforms rather than narrow detectors, and healthcare AI market projections show rapid expansion through 2033. That momentum is colliding with a fierce debate—CEOs claim AI could replace roles like radiologists in some workflows, while clinicians warn patient safety risks. (statnews.com) (openpr.com) (moneycontrol.com)
STAT’s April 2 analysis says the FDA is increasingly granting Breakthrough Device status to system‑level, multi‑problem AI platforms, pointing to recent Breakthrough grants to Aidoc (Sept. 30, 2025) and RecovryAI (Mar. 3, 2026). (statnews.com) Aidoc’s Sept. 30, 2025 designation explicitly enables “parallel review” of double‑digit indications in a single submission and ties that pathway to its CARE foundation model and aiOS enterprise platform. (appliedradiology.com) Policy momentum is tangible: STAT reported on July 30, 2025 that lawmakers and regulators have discussed making FDA “breakthrough” status a fast track to Medicare coverage, a move that would materially shorten time‑to‑revenue for platform AI. (statnews.com) Market forecasts diverge but agree on steep growth—Grand View Research projects the global AI‑in‑healthcare market will reach about $505.6 billion by 2033, while MarketsandMarkets estimates roughly $110.6 billion by 2030, underscoring wide variance in vendor and investor expectations. (grandviewresearch.com) Mitchell H. Katz, president and CEO of NYC Health + Hospitals, told a Crain’s New York Business forum on March 25 that “we could replace a great deal of radiologists with AI” if regulators “catch up,” signaling that an 11‑hospital public system is actively weighing AI‑first imaging workflows. (radiologybusiness.com) Clinicians pushed back immediately, warning of patient‑safety risks and sparking online criticism after Katz’s comments, and researchers at Harvard Medical School have published findings that poorly performing AI can sometimes degrade radiologist accuracy—evidence clinicians cite when urging caution. (moneycontrol.com)
